본문 바로가기
KERD
논문KCI 등재

Interpretation of androgen and anti-Mullerian hormone profiles in a Hispanic cohort of 5- to 8-year-old girls with premature adrenarche

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류소아과학

초록

Purpose: Premature adrenarche (PA) often leads to polycystic ovary syndrome (PCOS). Higher anti-mullerian hormone (AMH) levels are reported in PCOS. We studied the androgen profile and AMH profiles in Hispanic girls with PA (aged 5–8 years) and age and body mass index (BMI) matched controls. Methods: Retrospective review of electronic medical records of girls who met the inclusion criteria for premature adrenarche were done. Results: PA girls (n=76) were matched to control girls (n=12) for age (mean±standard deviation) (6.7±1 years vs. 6.2±1.3 years) and BMI (20±10 kg/m2 vs. 17.8±2.7 kg/ m2). Dehydroepiandrostenedione sulfate (63.3±51.3 µg/dL vs. 29.8±17.3 µg/dL, P<0.001) and testosterone levels (11.4±4.8 ng/dL vs. 8.2±2.9 ng/dL, P=0.001) were significantly higher in the PA group than controls. AMH values (<14 years: reference range, 0.49–3.15 ng/mL) were 3.2±2.2 ng/mL vs. 4.6± 3.2 ng/mL respectively in the PA and control groups and were not different (P=0.4). AMH did not show a correlation with bone age (P=0.1), and testosterone (P=0.9) in the PA group. 17-hydroxyprogesterone levels (17-OHP ng/dL) were 39.5±30.5 ng/dL vs. 36.8±19.8 ng/dL in PA versus control girls. The concentration of 17-OHP was not statistically different between the control and PA groups. Conclusion: Higher AMH was not observed in PA girls and no correlation with BA and androgen levels was observed.

Abstract

Purpose: Premature adrenarche (PA) often leads to polycystic ovary syndrome (PCOS). Higher anti-mullerian hormone (AMH) levels are reported in PCOS. We studied the androgen profile and AMH profiles in Hispanic girls with PA (aged 5–8 years) and age and body mass index (BMI) matched controls. Methods: Retrospective review of electronic medical records of girls who met the inclusion criteria for premature adrenarche were done. Results: PA girls (n=76) were matched to control girls (n=12) for age (mean±standard deviation) (6.7±1 years vs. 6.2±1.3 years) and BMI (20±10 kg/m2 vs. 17.8±2.7 kg/ m2). Dehydroepiandrostenedione sulfate (63.3±51.3 µg/dL vs. 29.8±17.3 µg/dL, P<0.001) and testosterone levels (11.4±4.8 ng/dL vs. 8.2±2.9 ng/dL, P=0.001) were significantly higher in the PA group than controls. AMH values (<14 years: reference range, 0.49–3.15 ng/mL) were 3.2±2.2 ng/mL vs. 4.6± 3.2 ng/mL respectively in the PA and control groups and were not different (P=0.4). AMH did not show a correlation with bone age (P=0.1), and testosterone (P=0.9) in the PA group. 17-hydroxyprogesterone levels (17-OHP ng/dL) were 39.5±30.5 ng/dL vs. 36.8±19.8 ng/dL in PA versus control girls. The concentration of 17-OHP was not statistically different between the control and PA groups. Conclusion: Higher AMH was not observed in PA girls and no correlation with BA and androgen levels was observed.

참고문헌 (39)

  1. Leung AK, "Premature adrenarche", J Pediatr Health Care, 22, pp.230~233 (2008)
  2. Liimatta J, "Serum androgen bioactivity is low in children with premature adrenarche", Pediatr Res, 75, pp.645~650 (2014)
  3. Voutilainen R, "Premature adrenarche:etiology, clinical findings, and consequences", J Steroid Biochem Mol Biol, 145, pp.226~236 (2015)
  4. Montalto J, "Serum 5-androstene-3 beta,17 beta-diol sulphate, sex hormone binding globulin and free androgen index in girls with premature adrenarche", J Steroid Biochem, 33, pp.1149~1154 (1989)
  5. Dorn LD, "Differences in endocrine parameters and psychopathology in girls with premature adrenarche versus on-time adrenarche", J Pediatr Endocrinol Metab, 21, pp.439~448 (2008)
  6. Ibáñez L, "Hyperinsulinemia and decreased insulin-like growth factor-binding protein-1 are common features in prepubertal and pubertal girls with a history of premature pubarche", J Clin Endocrinol Metab, 82, pp.2283~2288 (1997)
  7. Ibáñez L, "Hyperinsulinaemia, dyslipaemia and cardiovascular risk in girls with a history of premature pubarche", Diabetologia, 41, pp.1057~1063 (1998)
  8. Silfen ME, "Elevated free IGF-I levels in prepubertal Hispanic girls with premature adrenarche: relationship with hyperandrogenism and insulin sensitivity", J Clin Endocrinol Metab, 87, pp.398~403 (2002)
  9. Banerjee S, "Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: implications for polycystic ovarian syndrome", Pediatrics, 102, pp.E36~ (1998)
  10. Kousta E., "Premature adrenarche leads to polycystic ovary syndrome? Long-term consequences", Ann N Y Acad Sci, 1092, pp.148~157 (2006)
  11. Ibañez L, "Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism", J Clin Endocrinol Metab, 76, pp.1599~1603 (1993)
  12. Ibáñez L, "Polycystic ovaries after precocious pubarche: relation to prenatal growth", Hum Reprod, 22, pp.395~400 (2007)
  13. Rosenfield RL, "Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index", Pediatrics, 123, pp.84~88 (2009)
  14. Gavela-Pérez T, "Earlier menarcheal age in Spanish girls is related with an increase in body mass index between pre-pubertal school age and adolescence", Pediatr Obes, 10, pp.410~415 (2015)
  15. Ibáñez L, "Exaggerated adrenarche and hyperinsulinism in adolescent girls born small for gestational age", J Clin Endocrinol Metab, 84, pp.4739~4741 (1999)
  16. Hokken-Koèlega AC, "Timing of puberty and fetal growth", Best Pract Res Clin Endocrinol Metab, 16, pp.65~71 (2002)
  17. Zhang LH, "Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome", Proc Natl Acad Sci U S A, 92, pp.10619~10623 (1995)
  18. Ibáñez L, "Usefulness of an ACTH test in the diagnosis of nonclassical 21-hydroxylase deficiency among children presenting with premature pubarche", Horm Res, 44, pp.51~56 (1995)
  19. Pigny P, "Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome:relationship to the ovarian follicle excess and to the follicular arrest", J Clin Endocrinol Metab, 88, pp.5957~5962 (2003)
  20. Bayley N, "Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards", J Pediatr, 40, pp.423~441 (1952)
  21. Kuczmarski RJ, "2000 CDC Growth Charts for the United States: methods and development", Vital Health Stat, 11, pp.1~190 (2002)
  22. Collins WP, "Radioimmunoassay of plasma testosterone", J Steroid Biochem, 3, pp.333~348 (1972)
  23. Kumar A, "Development of a second generation anti-Müllerian hormone (AMH) ELISA", J Immunol Methods, 362, pp.51~59 (2010)
  24. Vaiarelli A, "Limited ability of circulating anti-Müllerian hormone to predict dominant follicular recruitment in PCOS women treated with clomiphene citrate: a comparison of two different assays", Gynecol Endocrinol, 32, pp.227~230 (2016)
  25. Wallace AM, "A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II)", Ann Clin Biochem, 48(Pt 4), pp.370~373 (2011)
  26. Hagen CP, "Individual serum levels of anti-Müllerian hormone in healthy girls persist through childhood and adolescence: a longitudinal cohort study", Hum Reprod, 27, pp.861~866 (2012)
  27. Paterson WF, "Exaggerated adrenarche in a cohort of Scottish children: clinical features and biochemistry", Clin Endocrinol (Oxf), 72, pp.496~501 (2010)
  28. Uçar A, "Pelvic ultrasound findings in prepubertal girls with precocious adrenarche born appropriate for gestational age", Clin Endocrinol (Oxf), 80, pp.699~705 (2014)
  29. Wu T, "Ethnic differences in the presence of secondary sex characteristics and menarche among US girls: the Third National Health and Nutrition Examination Survey, 1988-1994", Pediatrics, 110, pp.752~757 (2002)
  30. Ankarberg-Lindgren C, "Sensitive RIA measures testosterone concentrations in prepubertal and pubertal children comparable to tandem mass spectrometry", Scand J Clin Lab Invest, 75, pp.341~344 (2015)
  31. Diaz A, "Characteristics of children with premature pubarche in the new york metropolitan area", Horm Res, 70, pp.150~154 (2008)
  32. Sopher AB, "Prepubertal girls with premature adrenarche have greater bone mineral content and density than controls", J Clin Endocrinol Metab, 86, pp.5269~5272 (2001)
  33. DeSalvo DJ, "In children with premature adrenarche, bone age advancement by 2 or more years is common and generally benign", J Pediatr Endocrinol Metab, 26, pp.215~221 (2013)
  34. Sopher AB, "Bone age advancement in prepubertal children with obesity and premature adrenarche: possible potentiating factors", Obesity (Silver Spring), 19, pp.1259~1264 (2011)
  35. Bhide P, "Anti-Müllerian hormone and polycystic ovary syndrome", Best Pract Res Clin Obstet Gynaecol, 37, pp.38~45 (2016)
  36. Qi X, "The role of anti-Müllerian hormone in the pathogenesis and pathophysiological characteristics of polycystic ovary syndrome", Eur J Obstet Gynecol Reprod Biol, 199, pp.82~87 (2016)
  37. Łebkowska A, "Anti-Müllerian hormone and polycystic ovary syndrome", Endokrynol Pol, 68, pp.74~78 (2017)
  38. Crisosto N, "Anti-Müllerian hormone levels in peripubertal daughters of women with polycystic ovary syndrome", J Clin Endocrinol Metab, 92, pp.2739~2743 (2007)
  39. Utriainen P, "Serum antimüllerian hormone concentrations in prepubertal girls with and without premature adrenarche: The influence of body mass index", Horm Res Paediatr, 74, pp.207~211 (2010)

관련 논문AI추천

이 간행물의 다른 논문 (10건)